Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 2 (2018) NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
"... . In comparison of different DOACs against each other apixaban demonstrated lower bleeding risk while patients ..."
 
Vol 15, No 4 (2019) Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova
"... of this DOAC. The optimal efficacy and safety coupling of apixaban is reflected in the exclusively high ..."
 
Vol 13, No 6 (2017) PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS Abstract  similar documents
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin
"... the development of bleeding during anticoagulant therapy with direct oral anticoagulants (DOAC). Material ..."
 
Vol 15, No 6 (2019) Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation Abstract  similar documents
M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... and apixaban) demonstrated good safety profile without major bleeding within a 1.5-year follow-up period. ..."
 
Vol 10, No 4 (2014) NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... dabigatran, rivaroxaban and apixaban) is presented from the standpoint of safety. The safety profile ..."
 
Vol 9, No 4 (2013) COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS Abstract  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
"... Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... (warfarin), antiplatelet therapy (acetylsalicylic acid) and novel oral anticoagulants such as apixaban ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... therapy , last information about their efficacy , safety and potential of application. ..."
 
Vol 13, No 1 (2017) DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT Abstract  similar documents
D. А. Napalkov, A. A. Sokolova, V. V. Fomin
"... in patients with non-valvular atrial fibrillation. These results confirm good safety profile of apixaban which ..."
 
Vol 13, No 3 (2017) PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION Abstract  similar documents
A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko
"... 1045642 polymorphisms. ABCB1 gene rs4148738 polymorphism was associated with higher apixaban peak ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... of efficacy and safety of apixaban in patients with AF, depending on the presence of CHD, PAD, concomitant use ..."
 
Vol 16, No 1 (2020) The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation Abstract  similar documents
A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva
"... Aim. To study the efficacy, safety, and adherence to therapy with new oral anticoagulants ..."
 
Vol 12, No 3 (2016) THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE Abstract  PDF (Eng)  similar documents
A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko
"... Aim. To study pharmacokinetics of apixaban in patients with atrial fibrillation and cardioembolic ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... comparing clinical effectiveness and safety of apixaban with warfarin (ARISTOTLE) and acetylsalicylic acid ..."
 
Vol 11, No 5 (2015) Practical aspects of apixaban use in clinical practice: continuing the theme Abstract  similar documents
S. N. Bel'diev
"... Currently there are no generally accepted guidelines for the use of apixaban together with CYP3A4 ..."
 
Vol 15, No 2 (2019) Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova
 
Vol 10, No 3 (2014) EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION Abstract  similar documents
"... European Medicines Agency approved apixaban use in cardioversion. ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... and safety of apixaban with these of warfarin in patients with atrial fibrillation and a history of ischemic ..."
 
Vol 11, No 2 (2015) PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST Abstract  similar documents
D. A. Sychev, I. I. Sinitsina, G. Yu. Zakharova, M. I. Savel'eva, A. V. Ryabova, A. V. Kryukov, A. Yu. Yurovskii
"... Apixaban is a "new" oral anticoagulant, direct Xa factor inhibitor with a good evidence base ..."
 
Vol 11, No 6 (2015) Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events Abstract  similar documents
O. V. Shatalova
"... Aim. Pharmacoeconomic analysis of apixaban use compared to conventional therapy in patients ..."
 
Vol 13, No 5 (2017) DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov
 
Vol 13, No 1 (2017) CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
"... and apixaban in patients with non-valvular atrial fibrillation (AF) and to assess the impact of the both ..."
 
Vol 12, No 5 (2016) Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
I. S. Daabul, A. A. Sokolova, D. A. Napalkov
"... of the main studies didn't yield or exceeded warfarin concerning balance of efficiency and safety. However ..."
 
Vol 9, No 3 (2013) ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT Abstract  similar documents
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... administration of vitamin K antagonists (warfarin) or the new oral anticoagulants (apixaban, dabigatran ..."
 
Vol 15, No 5 (2019) Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review Abstract  similar documents
B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
 
Vol 16, No 1 (2020) Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice Abstract  similar documents
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko
 
Vol 14, No 6 (2018) Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding Abstract  PDF (Eng)  similar documents
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
"... anticoagulants (DOACs) inhibitors, as antidotes for DOAC when stopping life-threatening bleeding. DOAC therapy ..."
 
Vol 14, No 3 (2018) THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE Abstract  similar documents
I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... long-term anticoagulant therapy with apixaban in a full dose (5 mg b.i.d.), and the patient ..."
 
Vol 14, No 4 (2018) Hepatotoxicity of New Oral Anticoagulants Abstract  similar documents
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin
 
Vol 12, No 2 (2016) THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE Abstract  similar documents
S. V. Moiseev
"... New oral anticoagulants that inhibit factor Xa (rivaroxaban, apixaban, edoksaban) or thrombin ..."
 
Vol 15, No 4 (2019) According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention Abstract  similar documents
Company Pfizer
 
Vol 14, No 4 (2018) Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing Abstract  similar documents
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik
"... Background. Anticoagulants (AC) are the high-risk drugs. Their safety closely depends on physician ..."
 
Vol 11, No 3 (2015) PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT Abstract  similar documents
A. V. Rudakova
"... or oral anticoagulants that differ significantly in their efficacy, safety and cost of the therapy. Aim ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"...   of new OAC (NOAC) also appeared. In Russia, dabigatran, rivaroxaban and apixaban have been registered ..."
 
Vol 15, No 5 (2019) Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko
"... to direct oral anticoagulants (DOACs). In randomized clinical trials, meta-analyses and systematic reviews ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... Aim. To assess the cost-effectiveness of apixaban in the treatment and secondary prevention ..."
 
Vol 9, No 2 (2013) ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES Abstract  similar documents
Z. M. Safiullina, S. V. Shalaev
"... inhibitors of coagulation factor Xa (rivaroxaban, apixaban), in the treatment of nonvalvular atrial ..."
 
Vol 12, No 5 (2016) Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation Abstract  similar documents
N. A. Novikova, A. N. Volovchenko
"... showed the efficacy and safety of rivaroxaban and apixaban in preparation and performance of electrical ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) and real-world ..."
 
Vol 15, No 5 (2019) Findings Released from NAXOS Analysis. Pfizer Company Press Release Abstract  similar documents
article Editorial
"... Компания Pfizer представила результаты когортного исследования NAXOS (EvaluatioN of ApiXaban in ..."
 
Vol 16, No 1 (2020) Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients Abstract  similar documents
A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin
"... therapy turned out to be the most promising for clinical use, since studies with dabigatran and apixaban ..."
 
Vol 9, No 2 (2013) STATIN SAFETY REVISITED DATA Abstract  similar documents
O. M. Drapkina
"... safety in cardiac patients with liver diseases are presented. Features of statins use in nonalcoholic ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... Data about efficacy and safety of long-term therapy with acetylsalicylic acid in patients ..."
 
Vol 10, No 5 (2014) STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE Abstract  similar documents
L. N. Malay
"... of cardiovascular complications, good safety and tolerability profile were presented. Treatment of patients ..."
 
Vol 11, No 5 (2015) A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation Abstract  similar documents
E. I. Emelina, G. E. Gendlin
"... combination therapy is also considered. The safety of lercanidipine in cardiac patients is discussed ..."
 
Vol 1, No 2 (2005) STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY Abstract  similar documents
Y. A. Karpov
"... , aswell as problems of statin treatment safety. The choice of the drug must be based on clinical research ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF ACIDUM ACETYLSALICYLICUM USAGE Abstract  similar documents
V. N. Drozdov, V. A. Kim
"... Data about efficacy and safety of acetylsalicylic acid usage as antiplatelet drug and for cancer ..."
 
Vol 5, No 6 (2009) STATIN GENERICS: EFFICACY AND SAFETY RATIO Abstract  similar documents
V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova
"... choice between original and generic drugs is discussed taking into account efficacy and safety ratio. ..."
 
Vol 15, No 6 (2019) Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, N. A. Komkova
"... recommended the use of rivaroxaban; 47 (23.4%) – the use of dabigatran and 43 (21.4%) – the use of apixaban ..."
 
Vol 7, No 1 (2011) ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov
 
Vol 7, No 1 (2011) ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT? Abstract  similar documents
L. N. Malay
 
Vol 15, No 4 (2019) Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... . It often leads to a decrease in the efficacy of anticoagulant therapy without improving the drugs safety ..."
 
Vol 10, No 6 (2014) СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY? Abstract  similar documents
S. Yu. Martsevich, A. Yu. Suvorov
"... are considered. Safety of concomitant administration of clopidogrel and PPI, its impact on long-term outcomes ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... is - the lower risk of cardiovascular diseases and their complications are. Efficacy and safety of atorvastatin ..."
 
Vol 11, No 4 (2015) DRUGS EFFICIENCY AND SAFETY: THE ROLE OF PHARMACEUTICAL INDUSTRY Abstract  similar documents
F. I. Belyalov
 
Vol 9, No 2 (2013) ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS Abstract  similar documents
O. V. Shatalova, O. N. Smuseva, A. S. Maslakov
"... Regional Centre for Drug Safety Monitoring were used. Results. Regarding antithrombotic drugs 18 ..."
 
Vol 10, No 3 (2014) THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW Abstract  similar documents
D. A. Napalkov
"... Various aspects of the safety of statins in clinical practice are discussed: hepatotoxicity ..."
 
Vol 1, No 3 (2005) EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim
"... Aim. To assess in a short-term study efficiency and safety of hypolipidemic therapy ..."
 
Vol 14, No 6 (2018) Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety Abstract  PDF (Eng)  similar documents
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
"... Aim. To compare safety of new class III antiarrhythmic drug Refralon with direct current ..."
 
Vol 13, No 2 (2017) COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH Abstract  similar documents
O. M. Drapkina
"... Aim. To study the efficacy and safety of the use of combined antihypertensive therapy ..."
 
Vol 9, No 4 (2013) VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
 
Vol 3, No 3 (2007) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... that different ACE inhibitors may have the various efficacy and safety in patients with acute myocardial ..."
 
Vol 3, No 4 (2007) PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY Abstract  similar documents
B. A. Tatarskii
 
Vol 14, No 5 (2018) Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness Abstract  similar documents
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
 
Vol 15, No 5 (2019) Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris Abstract  similar documents
V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova
 
Vol 6, No 3 (2010) SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION Abstract  similar documents
D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko
 
Vol 7, No 5 (2011) COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... Aim. To compare efficacy , emsafety/em and pharmacoeconomical characteristics of generic and original ..."
 
Vol 6, No 5 (2010) THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY Abstract  similar documents
T. V. Kozlova, I. M. Makeyeva, V. Y. Doroshina, S. I. Bokareva
 
Vol 9, No 1 (2013) THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE Abstract  similar documents
M. V. Lebedeva, V. D. Beketov, N. V. Maltsev, M. E. Safarova
 
Vol 8, No 2 (2012) EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva
"... efficacy and emsafety/em in primary and secondary prevention are presented. The main groups of patients who ..."
 
Vol 14, No 2 (2018) MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. F. Zadvorev, A. A. Yakovlev, A. S. Pushkin, S. A. Rukavishnikova, A. E. Filippov, A. G. Obrezan
"... for controlling the emsafety/em of the long-term digoxin treatment, however, the benefits from SDC monitoring ..."
 
Vol 5, No 3 (2009) SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS Abstract  similar documents
E. S. Kropacheva
"... The emsafety/em of anticoagulant therapy is discussed. Warfarin position in prevention of thrombotic ..."
 
Vol 5, No 4 (2009) GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY Abstract  similar documents
A. L. Komarov
 
Vol 7, No 2 (2011) EFFICACY AND SAFETY OF BISOPROLOL IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND OBESITY Abstract  similar documents
A. G. Avtandilov, I. I. Esenova, S. L. Petrosov
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
 
Vol 7, No 6 (2011) NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina
"... , but it is superior to amiodaron in emsafety/em. However , in 2011 dronedarone was included in the Food and Drug ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
 
Vol 8, No 5 (2012) THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN Abstract  similar documents
R. I. Striuk, Ya. V. Brytkova
"... into the category C according to emsafety/em classification of Food and Drug Administration (US FDA). Their prescription ..."
 
Vol 14, No 4 (2018) Main Approaches to Assessing the Quality of Drug Therapy in Cardiology Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, N. A. Komkova, N. A. Dmitrieva, O. A. Drapkina
"... emsafety/em parameters and efficacy of the prescribed drug. In addition, a review of the methods and scales ..."
 
Vol 15, No 5 (2019) Efficacy, Safety and Long-term Outcomes of Nicorandil Use in Patients with Stable Ischemic Heart Disease According to the Results of Randomized and Observational Studies Abstract  similar documents
Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich
"... the data on the effectiveness and emsafety/em of nicorandil in pts with stable IHD obtained in the NIKEA ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
 
Vol 15, No 6 (2019) New Opportunities for Improving the Prognosis of Patients with Chronic Ischemic Heart Disease Abstract  similar documents
N. B. Perepech
"... and anticoagulants. The results of the most significant randomized clinical trials of the efficacy and emsafety/em ..."
 
Vol 1, No 1 (2005) DRUGS AND SMOKING Abstract  similar documents
J. V. Lukina
"... Smoking is a well – known risk factor of many diseases. It influences the efficacy and emsafety/em ..."
 
Vol 13, No 5 (2017) ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT Abstract  similar documents
S. G. Kanorskii
"... clinical practice have demonstrated its emsafety/em and efficacy in patients with AF, including the elderly ..."
 
Vol 7, No 4 (2011) EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
E. I. Makhiyanova, A. S. Galyavich
"...   Aim. To study of efficacy and emsafety/em of glycoprotein IIb/IIIa blocker monafram in acute ST ..."
 
Vol 7, No 5 (2011) EFFICACY AND SAFETY OF IVABRADINE AND BISOPROLOL IN PATIENTS WITH ISCHEMIC HEART DISEASE: RESULTS OF COMPARATIVE RANDOMIZED OPEN STUDY Abstract  similar documents
R. D. Kurbanov, A. O. Kan, F. M. Bekmetova, A. B. Shek
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... Aim. To study the effectiveness of achievement of lipid profile target levels and emsafety/em ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... -term emsafety/em and efficacy of full dose rosuvastatin and atorvastatin in patients with acute coronary ..."
 
Vol 5, No 2 (2009) EFFICACY AND SAFETY OF FIXED COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE FOR MANAGEMENT OF VASCULAR DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
L. A. Haisheva
"... function indicators were founded in both groups of therapy. This fixed combination had also a good emsafety/em ..."
 
Vol 5, No 4 (2009) EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH RENOPARENCHYMAL ARTERIAL HYPERTENSION IN ACTUAL CLINICAL PRACTICE Abstract  similar documents
N. J. Borovkova, N. N. Borovkov, T. I. Maslov
"... Aim. To evaluate efficacy and emsafety/em of combined antihypertensive therapy based on ramipril ..."
 
Vol 5, No 5 (2009) EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES Abstract  similar documents
O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova
"... Aim. To evaluate a short-term efficacy and emsafety/em of nebivolol and carvedilol in hypertensive ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS Abstract  similar documents
O. L. Barbarash, M. V. Zykov
"... Aim. To evaluate efficacy, emsafety/em and influence on quality of life of controlled release ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF AMLODIPINE MALEATE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND BRONCHIAL ASTHMA WITH CONCOMITANT ARTERIAL HYPERTENSION Abstract  similar documents
N. A. Karoli, A. P. Rebrov, A. A. Roshchina, V. A. Sergeeva, E. E. Arkhangelskaya
"... Aim. To evaluate efficacy and emsafety/em of amlodipine maleate in patients with chronic obstructive ..."
 
Vol 4, No 1 (2008) COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich
 
Vol 4, No 2 (2008) COMPARATIVE STUDY OF EFFICIENCY AND SAFETY OF THE NEW DRUG OF AMLODOPINE – S-AMLODOPINE IN PATIENTS WITH ARTERIAL HYPERTENSION OF I-II DEGREE Abstract  similar documents
M. A. Maksimova, Y. V. Lukina, S. N. Tolpygina, E. V. Shilova, N. A. Dmitrieva, S. Y. Martsevich
"... Aim. To evaluate efficacy and emsafety/em of a new drug of amlodipine – S-amlodipine (Azomex, Emcur ..."
 
Vol 4, No 4 (2008) EFFICACY AND SAFETY OF GINKGO BILOBA IN ELDERLY PATIENTS WITH CONTROLLED ARTERIAL HYPERTENSION AND CIRCULATORY ENCEPHALOPATHY Abstract  similar documents
V. V. Jakusevich, N. V. Semenova, I. A. Tihomirova, A. V. Muravyov, S. V. Lychenko
 
1 - 100 of 240 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)